AIxMed Welcomes Barbara Crothers, D.O., as Chief Scientist and Appoints Two Scientific Advisors
SANTA CLARA, Calif., June 5, 2023 /PRNewswire/ --Â AIxMed, an early-stage smart Cytology company at the intersection of artificial intelligence (AI) and medicine, announced the appointment of Cytopathology industry heavyweight Barbara Crothers, D.O., as Chief Scientist. In this new executive leadership role, Dr. Crothers will drive AIxMed's strategic scientific and clinical initiatives. This includes leading U.S.-based pilot and validation studies of the AIxMed digital Cytology platform.
- In this new executive leadership role, Dr. Crothers will drive AIxMed's strategic scientific and clinical initiatives.
- This includes leading U.S.-based pilot and validation studies of the AIxMed digital Cytology platform.
- Dr. Crothers is joining in our AI-driven mission to improve workflows and patient care in the battle against cancer.
- At AIxMed, she will apply these strong credentials towards positioning the Company's technology at the leading edge of the Pathology digital revolution.